BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 32553314)

  • 1. Impact of UDST: A step forward to end TB.
    Kumar Sharma A; Vijay S; Mathur RB; Meena H
    Indian J Tuberc; 2020 Apr; 67(2):213-215. PubMed ID: 32553314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of universal drug susceptibility testing among people with TB in a south Indian district: How are we faring?
    Ranganath R; Shewade HD; Bahadur AK; Naik V; Nagaraja SB; Kumar AMV; Peerapur BV; Babu S; Somshekhar N; Singarajipur A
    Trans R Soc Trop Med Hyg; 2022 Jan; 116(1):43-49. PubMed ID: 33823556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study on procedural delay in diagnosis and start of treatment in drug resistant tuberculosis under RNTCP.
    Sharma AK; Gupta N; Verma S; Chandran A; Dixit R
    Indian J Tuberc; 2019 Jul; 66(3):394-401. PubMed ID: 31439186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia.
    Ershova JV; Volchenkov GV; Somova TR; Kuznetsova TA; Kaunetis NV; Kaminski D; Demikhova OV; Chernousova LN; Vasilyeva IA; Kerr EM; Cegielski JP; Kurbatova EV
    BMC Infect Dis; 2020 Jul; 20(1):543. PubMed ID: 32711457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric TB Management under RNTCP: What and Why?
    Singh V
    Indian J Pediatr; 2019 Aug; 86(8):707-713. PubMed ID: 31250349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Has introduction of rapid drug susceptibility testing at diagnosis impacted treatment outcomes among previously treated tuberculosis patients in Gujarat, India?
    Dave P; Vadera B; Kumar AM; Chinnakali P; Modi B; Solanki R; Patel P; Patel P; Pujara K; Nimavat P; Shah A; Bharaswadkar S; Rade K; Parmar M; Nair SA
    PLoS One; 2015; 10(4):e0121996. PubMed ID: 25874545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoniazid mono-resistant tuberculosis: Time to take it seriously.
    Garg K; Saini V; Dhillon R; Agarwal P
    Indian J Tuberc; 2019 Apr; 66(2):247-252. PubMed ID: 31151492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Using the Quantamatrix Multiplexed Assay Platform System.
    Wang HY; Uh Y; Kim S; Cho E; Lee JS; Lee H
    Ann Lab Med; 2018 Nov; 38(6):569-577. PubMed ID: 30027701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of drug-resistant TB and provision of second-line TB treatment in India: some ethical considerations.
    Singh JA; Bhan A; Upshur R
    Indian J Med Ethics; 2013; 10(2):110-4. PubMed ID: 23697491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of the Xpert MTB/RIF assay for tuberculous lymphadenitis on fine needle aspirates from Ethiopia.
    Biadglegne F; Mulu A; Rodloff AC; Sack U
    Tuberculosis (Edinb); 2014 Sep; 94(5):502-5. PubMed ID: 24931451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are WHO approved nucleic acid amplification tests causing large-scale "false identification" of rifampicin-resistant tuberculosis?: Programmatic experience from south india.
    Sanker P; Ambika AP; Santhosh VT; Kottuthodi RP; Balakrishnan R; Mrithunjayan SK; Moosan H
    Int J Mycobacteriol; 2017; 6(1):21-26. PubMed ID: 28317800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Status of universal drug-susceptibility testing among sputum smear-positive tuberculosis patients diagnosed at a tertiary care centre.
    Debolina P; Palanivel C; Manju R; Tanveer R
    Indian J Med Res; 2023; 157(2&3):216-219. PubMed ID: 37202940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile of drug-resistant-conferring mutations among new and previously treated pulmonary tuberculosis cases from Aligarh region of Northern India.
    Ahmed S; Shukla I; Fatima N; Varshney SK; Shameem M; Tayyaba U
    Int J Mycobacteriol; 2018; 7(4):315-327. PubMed ID: 30531028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania.
    Pimkina E; Zablockis R; Nikolayevskyy V; Danila E; Davidaviciene E
    Respir Med; 2015 Nov; 109(11):1484-9. PubMed ID: 26403251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Introducing Xpert MTB/RIF on Diagnosis and Treatment of Drug-Resistant Tuberculosis Patients in Indonesia: A Pre-Post Intervention Study.
    van Kampen SC; Susanto NH; Simon S; Astiti SD; Chandra R; Burhan E; Farid MN; Chittenden K; Mustikawati DE; Alisjahbana B
    PLoS One; 2015; 10(6):e0123536. PubMed ID: 26075722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct detection of Mycobacterium tuberculosis and drug resistance in respiratory specimen using Abbott Realtime MTB detection and RIF/INH resistance assay.
    Tam KK; Leung KS; To SW; Siu GK; Lau TC; Shek VC; Tse CW; Wong SS; Ho PL; Yam WC
    Diagn Microbiol Infect Dis; 2017 Oct; 89(2):118-124. PubMed ID: 28780247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Feasibility of Xpert MTB/RIF Testing to Detect Rifampicin Resistance among Childhood Tuberculosis for Prevalence Surveys in Northern China.
    Lu J; Li H; Dong F; Shi J; Yang H; Han S; Chu P; Zhao Y; Song W; Guo Y; Zhao S
    Biomed Res Int; 2017; 2017():5857369. PubMed ID: 29359155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study.
    Abanda NN; Djieugoué JY; Lim E; Pefura-Yone EW; Mbacham WF; Vernet G; Penlap VM; Eyangoh SI; Taylor DW; Leke RGF
    BMC Infect Dis; 2017 May; 17(1):379. PubMed ID: 28569148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa.
    Rabna P; Ramos J; Ponce G; Sanca L; Mané M; Armada A; Machado D; Vieira F; Gomes VF; Martins E; Colombatti R; Riccardi F; Perdigão J; Sotero J; Portugal I; Couto I; Atouguia J; Rodrigues A; Viveiros M
    PLoS One; 2015; 10(5):e0127536. PubMed ID: 26017968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistance patterns among extra-pulmonary tuberculosis cases in a tertiary care centre in North India.
    Sharma SK; Chaubey J; Singh BK; Sharma R; Mittal A; Sharma A
    Int J Tuberc Lung Dis; 2017 Oct; 21(10):1112-1117. PubMed ID: 28911354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.